Abrezekimab (VR 942) is composed of CDP7766, leucine, and trehalose. Abrezekimab is a humanized antibody that targets human IL-13. Abrezekimab inhibits binding to IL-13Ralpha1 subunit. Abrezekimab can be used to study biological disorders associated with ast
CAS Number:
[2043952-59-4]
Target:
UCB4144 , VR 942
* VAT and and shipping costs not included. Errors and price changes excepted